LAVA Therapeutics N.V.
NASDAQ:LVTX
1.26 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 35.015 | 44.231 | 100.333 | 151.014 | 19.429 | 8.326 |
| Short Term Investments
| 41.561 | 51.34 | 32.535 | 47.995 | 0 | 0 |
| Cash and Short Term Investments
| 76.576 | 95.571 | 132.868 | 151.014 | 19.429 | 8.326 |
| Net Receivables
| 0 | 1.699 | 3.254 | 0.734 | 1.472 | 0.219 |
| Inventory
| 0 | 0 | 0 | -48.827 | 0.997 | 0 |
| Other Current Assets
| 2.721 | 1.627 | 4.411 | 2.568 | 0.928 | 0.062 |
| Total Current Assets
| 79.297 | 98.897 | 140.533 | 154.757 | 22.384 | 8.646 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 1.443 | 2.494 | 2.083 | 2.206 | 1.836 | 1.301 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.091 | 0.319 | 0.809 | 0.902 | 0.944 | 0.034 |
| Total Non-Current Assets
| 1.534 | 2.813 | 2.892 | 3.109 | 2.78 | 1.335 |
| Total Assets
| 80.831 | 101.71 | 143.425 | 157.866 | 25.164 | 9.981 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.722 | 4.446 | 3.965 | 2.553 | 0.934 | 0.422 |
| Short Term Debt
| 0.315 | 5.722 | 5.019 | 0.261 | 1.681 | 0.236 |
| Tax Payables
| 0 | 0 | 0.045 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 35 | 1.731 | 5.355 | 0.853 |
| Other Current Liabilities
| 14.969 | 4.773 | 12.925 | 6.907 | 3.147 | 0.958 |
| Total Current Liabilities
| 18.006 | 14.941 | 21.954 | 5.025 | 8.809 | 1.616 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.16 | 0.591 | 0.431 | 4.604 | 3.875 | 1.529 |
| Deferred Revenue Non-Current
| 0 | 35 | 35 | 1.731 | 2.232 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -4.732 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 34.92 | 0 | 0 | 5.028 | 1.463 | 0.206 |
| Total Non-Current Liabilities
| 35.08 | 35.591 | 35.431 | 18.647 | 6.993 | 1.735 |
| Total Liabilities
| 53.086 | 50.532 | 57.385 | 23.672 | 15.802 | 3.35 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 3.717 | 3.715 | 3.715 | 4.141 | 0 | 0 |
| Retained Earnings
| -174.973 | -148.067 | -108.069 | -89.26 | -44.355 | -15.549 |
| Accumulated Other Comprehensive Income/Loss
| -12.655 | -10.899 | -4.03 | 1.334 | 0.685 | -0.015 |
| Other Total Stockholders Equity
| 211.656 | 206.429 | 194.424 | 192.27 | 43.751 | 20.713 |
| Total Shareholders Equity
| 27.745 | 51.178 | 86.04 | 134.194 | 9.362 | 6.631 |
| Total Equity
| 27.745 | 51.178 | 86.04 | 134.194 | 9.362 | 6.631 |
| Total Liabilities & Shareholders Equity
| 80.831 | 101.71 | 143.425 | 157.866 | 25.164 | 9.981 |